Abstract
Introduction
Coronary artery disease (CAD) is the most common single cause of death in developed countries [1] . In Poland, the standardized death rate from ischemic heart disease in people under 65 years of age is 24 per 100,000 and the number of ischemic heart disease deaths is 45,000 yearly [2, 3] . In recent years, rapid development in pharmacological as well as invasive CAD treatment methods has been observed. Nevertheless, the results of a mortality follow-up of the European Action on Secondary Prevention through Intervention to Reduce Events (EUROASPIRE) I-III surveys indicate that risk factors remain independent predictors of cardiovascular mortality in CAD patients [4] . The conclusion from another 5-year follow-up survey is that smoking cessation, providing advice on diet and ensuring optimal pharmacological treatment are crucial factors in reducing mortality in patients who have suffered myocardial infarction (MI) [5] . Thus, the highest priority for preventive cardiology was given to patients with established CAD [6] .
The Cracovian Program for Secondary Prevention of Ischemic Heart Disease was launched in 1996 [7, 8] . The main goal of the program was to assess and improve the quality of medical care in the field of secondary CAD prevention. Later, the same centers took part in the EUROASPIRE surveys [9] . These projects allowed the assessment of temporal changes in the implementation of recommendations as well as international comparisons [9] [10] [11] . However, not much is known about the relation between types of acute coronary syndrome (MI vs. unstable angina [UA] ) and the quality of secondary prevention in Poland. It is also not known whether CAD patients who have undergone a myocardial revascularization procedure receive better quality medical care than non-revascularized patients. The aim of the present study was to assess the recent status of implementation of the guidelines for secondary prevention in everyday clinical practice by assessing control of the main risk factors and the cardioprotective medication prescription rates in patients after hospitalization for CAD.
Methods
The study groups and the methods used in the Cracovian Program for Secondary Prevention of Ischemic Heart Disease and Polish part of EUROASPIRE surveys were described in earlier reports [10, 11] . A brief description is given below.
Five hospitals with cardiology departments, serving the city and its surrounding districts in the southern part of Poland participated in the study. Total population of this area is about 1,200,000 inhabitants. In each department, medical records of consecutive patients hospitalized from January 1 2010 to April 31 2012 due to acute MI (first or recurrent, no prior percutaneous coronary intervention [PCI] or coronary artery bypass grafting [CABG]), UA (first or recurrent, no prior PCI or CABG), PCI (first, no prior CABG) or scheduled for CABG (first) were reviewed and patients aged ≤ 80 years were identified retrospectively excluding those who had died during their in-hospital stay and those who were scheduled for CABG combined with valve surgery. If a patient was hospitalized more than once within the study period, only the first hospitalization was accepted as an index event. The medical records of patients fulfilling the inclusion criteria were analyzed using the standardized data collection form.
Participants were invited to take part in the follow-up examination 6-18 months after discharge. Data on demographic characteristics, personal history of CAD, smoking status, blood pressure, fasting glucose, plasma lipids, and prescribed medications were obtained using a standardized data collection form. The patients' height and weight were measured in a standing position without shoes and heavy outer garments using standard scales with a vertical ruler. Body mass index (BMI) was calculated according to the following formula:
2 . Blood pressure was measured twice, on the right arm in a sitting position after at least 5 min of rest. For plasma lipid and glucose measurements a fasting venous blood sample was taken between 7:30 and 8:30 in the morning. For the present report, results of the analyses which were done no later than 4 h after blood collection were used. Low density lipoprotein-cholesterol (LDL-C) levels were calculated according to Friedewald formula.
We also calculated the secondary prevention coefficient: for each risk factor controlled (not smoking, blood pressure < 140/90 mm Hg, LDL-C < 1.8 mmol/l, glycated hemoglobin [HbA 1c ] < 7.0%, BMI < 25 kg/m 2 ) during the follow-up interview one point was given. Additionally, one point was given for taking an antiplatelet agent and an angiotensin converting enzyme inhibitor (ACEI) or a sartan. Thus, the secondary prevention coefficient could vary from 1 to 7. The survey protocol was approved by the institutional Bioethics Committee.
Statistical analysis
Categorical variables were reported as percentages and continuous variables as means ± standard deviation. The Pearson c 2 test was applied to all categorical variables. Normally distributed continuous variables were compared by using the Student's t test or analysis of variance. Variables without normal distributions were evaluated using the Mann-Whitney U test or the Kruskal-Wallis analysis of variance. Stepwise multivariate analysis was performed using the multivariate regression analysis as implemented in the STATISTICA 8.0 software (StatSoft INC., Tulsa, USA). Adjusted R 2 statistic was used as an indicator of the best statistical model. A 2-tailed p value < 0.05 was regarded as indicating statistical significance.
Results
The medical records of 595 patients were reviewed and included in the analyses. The mean age, sex and proportion of men to women by survey are presented in Table 1 . The patients from the PCI group were the youngest, whereas the proportion of women was the highest in the UA group. The proportions of medical records with available information on risk factors are presented in the Table 2 . We found no major differences in the proportions of medical records with available information on risk factors between index diagnoses with the exception of weight and height. The proportion of medical records with available information on weight and height was significantly lower in the CABG and MI groups when compared with the other index diagnoses. Cardioprotective drugs prescription rates at discharge are shown in Table 3 . The prescription rate of beta-blockers (BB), ACEI or sartans, calcium antagonists, lipid--lowering drugs, and anticoagulants differed between the index diagnoses, whereas the prescription rate of antiplatelets and diuretics were similar across groups.
Out of the 595 invited patients 380 (63.9%) participated in the follow-up examination 6-18 months after discharge from hospital. The participation rate differed significantly across the index events: MI group -55.4%, UA group -65.4%, PCI group -81.8%, CABG group -68.4% (p < 0.05). No significant differences were found between men and women (63.5% vs. 64.6%, p = NS). There were no significant differences in mean age of those who underwent a follow-up examination and those who did not (62.6 ± 8.6 years vs. 63.2 ± 9.7 years, p = NS).
The study participants did not differ significantly between the index events in respect of the duration of education, employment, practice setting, and the specialization of the physician deciding on the course of management (Table 1) . Overall, 33.9% of the study participants declared they had been advised to participate in a rehabilitation/ secondary prevention program following the index hospitalization (MI 39.2%, UA 32.8%, PCI 21.0%, CABG 50.0%; p < 0.05) and 30.5% participated in a rehabilitation/secondary prevention program following the index hospitalization. However, only 28.2% took part in at least half of the planned sessions (MI 32.4%, UA 25.6%, PCI 17.3%, CABG 50.0%; p < 0.05).
We found that 20.3% of the participants smoked, 47.2% had high blood pressure, 72.8% high LDL-C level, 13.9% had HbA 1c ≥ 7.0%, and 37.8% were obese 6-18 months after discharge (Table 4) . No significant relation between the index events and the control of risk factors was found. Proportion of patients taking antiplatelets, BB, ACEI/sartans, diuretics, lipid-lowering drugs, and antidiabetic agents did not differ significantly between the index groups ( Table 5 ). The only significant difference was higher proportion of patients from the UA group taking calcium antagonists as compared with the MI group (p < 0.01), and higher proportion of CABG participants taking anticoagulants when compared with the MI (p < 0.05) and UA (p < 0.05) groups. The proportions of smokers being ever instructed on methods of smoking cessation are presented in Table 6 , whereas the proportions of patients being ever instructed in healthy diet are presented in Table 7 . The study groups did not differ in proportions of participants instructed in smoking cessation methods or healthy diet.
The mean secondary prevention coefficient was 4.35 ± 1.08. In the univariate analysis, the secondary prevention coefficient was related Table 6 . Proportions of smokers (before the index hospitalization or at the time of the follow-up examination) being ever instructed by a physician on smoking cessation (as declared by the patients). to participation in the rehabilitation/secondary prevention program following the index hospitalization, yet not to the index event (Table 8) . In a multivariate model, the secondary prevention coefficient was related to the patient's age, education and participation in a rehabilitation/secondary prevention program following the index hospitalization (Table 9) .
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Discussion
In general, our results did not show a big improvement in the management of patients after hospitalization for CAD as compared to the previous survey which was finished in 2012 [11] . As in the previous surveys we found considerable potential for further reduction of cardiovascular risk in CAD patients [8, 10, 11] .
Unfortunately, no study published in recent years was designed to assess secondary prevention of CAD outside Krakow. However, some recently published data from registries of patients hospitalized due to acute coronary syndromes are available [12, 13] . In a nation-wide registry of acute coronary syndrome hospitalizations it was estimated that the average prescription rate at discharge for aspirin and lipid lowering agents was slightly below 90%, and for BB and ACEI below 80% [12] . In 3,564 patients hospitalized for ST-elevation MI in Greater Poland, the prescription rates were 96% for antiplatelet agents, 74% for BB, 58% for ACEI and 90% for statins [13] . It should be stressed that the prescription rates of cardiopreventive medications in Poland are similar to the average prescription rates in centers participating in the EUROASPIRE III Survey [9] , and much higher compared to centers from high-income countries participating in the PURE Study [14] .
The present results confirm the observations of the survey carried out in 2006-2007 which suggested no major sex-related difference in the pro- portions of patients who achieved recommended treatment targets in secondary prevention [15] . We also showed that older patients (age ≥ 70 years) smoked less frequently compared to patients aged < 60 [15] . On the other hand, fewer patients aged ≥ 70 years had blood pressure < 140/90 mm Hg when compared with younger subjects. No major age-related difference in respect to the other main risk factors or prescriptions rates of cardioprotective medications was found [15] . Indeed, the present results confirm that in general, older age (at least up to 80 years) is not related to lower standard of medical care in the field of secondary prevention. It should be emphasized that the present results still suggest insufficient control over all main cardiovascular risk factors. As one of the important determinants of reaching the treatment targets is participation in the secondary prevention/cardiac rehabilitation programs, the finding that the low and decreasing proportion of patients had been advised to participate in the secondary prevention program/cardiac rehabilitation does not allow being optimistic. Indeed, in the previous report we showed that the proportion of patients who were advised to participate in such programs was 53.9% in 2005-2006 and 47.1% in 2010-2011, whereas the proportions of patients who finally participated in a rehabilitation/secondary prevention program were 35.9% and 33.3%, respectively [11] . It was shown that such programs result in better control of risk factors and improve prognosis [16] [17] [18] . Indeed, it seems that a higher participation rate in the secondary prevention/cardiac rehabilitation programs could result in better control of risk factors. Itshould be also stressed that the improved cooperation between hospital and outpatient clinic staff, as well as better access to a cardiologist in case of any suspicion of heart-related problems could further improve the patients' prognosis. Recently, experts from the Polish Cardiac Society described the "Optimal Model of Comprehensive Rehabilitation and Secondary Prevention", wide implementation of which in Poland could be related to a decrease in the number of deaths by 3,389, in the number of MIs by 3,872, in the number of myocardial revascularization procedures by 13, 499 , and in the number of cardiac hospitalizations by 23,182 yearly [19] .
Limitations of the study
The present study has some limitations. Firstly, we were unable to assess the impact of secondary prevention guidelines on the risk of cardiovascular complications. Secondly, our study participants were not representative of all CAD patients. Participants were limited to those who had experienced an acute CAD event or had undergone a revascularization procedure. Therefore, our results should not be directly applied to other CAD patients. Finally, we did not analyze the doses of cardioprotective drugs taken by the patients. It is possible that blood pressure, cholesterolemia, and glycemia were not controlled in some cases due to insufficient doses of the drugs prescribed. It should also be pointed out that we had no information on the patients' compliance with instructions regarding prescriptions. It is reasonable to suspect that some patients had been taking their medications irregularly.
Conclusions
Our data provide evidence that there is a considerable potential for further reduction of cardiovascular risk in CAD patients. Our results suggest that increasing the participation rate in rehabilitation/secondary prevention programs may improve the implementation of the secondary prevention guidelines.
